Tower Research Capital LLC (TRC) - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 11 filers reported holding EVOKE PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$5,000
+150.0%
10,807
+160.0%
0.00%
Q4 2021$2,000
-33.3%
4,157
+257.1%
0.00%
Q4 2020$3,000
-91.2%
1,164
-83.8%
0.00%
Q3 2020$34,000
+3300.0%
7,169
+7069.0%
0.00%
Q2 2016$1,000
-80.0%
100
-89.9%
0.00%
-100.0%
Q1 2016$5,000
-66.7%
991
-78.5%
0.00%
-50.0%
Q4 2015$15,000
+114.3%
4,599
+229.4%
0.00%
+100.0%
Q2 2015$7,000
+600.0%
1,396
+598.0%
0.00%
Q1 2015$1,0000.0%200
-1.0%
0.00%
Q4 2014$1,000
-66.7%
202
-59.6%
0.00%
Q3 2014$3,000
+200.0%
500
+495.2%
0.00%
Q2 2014$1,000840.00%
Other shareholders
EVOKE PHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 175,000$448,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 500,000$1,280,0000.22%
PRECEPT MANAGEMENT LLC 95,000$243,0000.15%
Family Management Corp 10,425$27,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$1,024,0000.01%
Acrospire Investment Management LLC 2,489$6,0000.01%
A.R.T. Advisors, LLC 15,413$39,0000.00%
NORTHERN TRUST CORP 29,214$75,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 23,048$59,0000.00%
DEUTSCHE BANK AG\ 200$00.00%
View complete list of EVOKE PHARMA INC shareholders